AzTrials
AzTrials

StrokeAutoRReViNCT04694833

Telerehabilitation Through Serious Games in Virtual Reality in a Stroke Population (AutoRReVi)

A study testing Motor and cognitive virtual reality-based assessments and Motor and cognitive virtual reality-based serious games in people with Stroke and Hemiparesis, run by Université Catholique de Louvain at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

After a stroke, individuals present with motor and/or cognitive impairments. These impairments limit activity, restrict participation and affect quality of life. Therefore, rehabilitation programs are provided from the earliest days. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke, Hemiparesis, Cognitive Impairment
What is being tested?
Motor and cognitive virtual reality-based assessments and Motor and cognitive virtual reality-based serious games
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteBelgium
Study dates
23 Oct 2020to 15 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Stroke patients (with hemiparesis or cognitive impairment such as apraxia, aphasia or hemineglect) OR healthy subjects
  • Able to undersand simple instructions

Who cannot join

  • Other disease that could affect upper limb motor function or cognition

Trial locations and contacts

1 site in 1 country.

Gauthier Everard, MSc, PT contact

+32472500158

gauthier.everard@uclouvain.be

Khawla Ajana, MSc contact

khawla.ajana@uclouvain.be

Belgium1 site, 1 recruiting
  • Cliniques universitaires Saint-Luc

    Brussels, Woluwé, 1200

    Thierry Lejeune, Pr, thierry.lejeune@uclouvain.be

    Thierry Lejeune, Pr

    Recruiting

Other trials in Belgium

About this study

Official title: Self-assessment and Telerehabilitation Using Virtual Reality Devices and Serious Games to Improve Motor and Cognitive Impairments in Stroke Patients

After a stroke, individuals present with motor and/or cognitive impairments. These impairments limit activity, restrict participation and affect quality of life. Therefore, rehabilitation programs are provided from the earliest days. However, an important proportion of patients do not achieve the recommended amount of rehabilitation therapy (even in institutional systems). In fact, patients do not always have access to healthcare systems. Moreover, hospital resources and healthcare systems are often limited (especially in poor countries) which has led to the development of new cost-effective rehabilitation methods such as self-rehabilitation and tele-rehabilitation.

This study aims :

  1. to develop and validate relevant self-assessments tools in virtual reality
  2. to propose auto-adaptative virtual reality-based therapies based on the link between motor and cognitive functions.
Being tested
Motor and cognitive virtual reality-based assessments, Motor and cognitive virtual reality-based serious games
Medical subject headings
Stroke, Paresis, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor and cognitive virtual reality-based assessmentsBehavioural

    Motor and cognitive testing in virtual reality

  • Motor and cognitive virtual reality-based serious gamesBehavioural

    Serious games implemented in virtual reality to rehabilitate motor and cognitive impairments.

Study groups in NCT04694833
Study groupRoleWhat they receive
Stroke patientsExperimentalStroke patients with hemiparesis and/or cognitive impairments (such as apraxia, aphasia and hemineglect)
Receives: Behavioral: Motor and cognitive virtual reality-based assessments; Behavioral: Motor and cognitive virtual reality-based serious games
Healthy subjectsExperimentalSubjects who do not suffer from any pathology that could affect upper-limb motor function or cognition
Receives: Behavioral: Motor and cognitive virtual reality-based assessments; Behavioral: Motor and cognitive virtual reality-based serious games

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Upper Extremity Fugl-Meyer Assessment

    Highly recommended scale that assess upper limb motor function (0% = worse outcome; 100% best outcome).

    Measured: Through study completion, on average 24 weeks

  2. Box and Block Test

    A measure of manual dexterity and activity that requires repeatedly moving 1-inch blocks from one side of a box to another in 60 seconds.

    Measured: Through study completion, on average 24 weeks

  3. The Bells Test

    A cancellation task, permits a quantitative and qualitative evaluation of visual neglect

    Measured: Through study completion, on average 24 weeks

  4. Action Research Arm Test

    A 19 item observational measure used by physical therapists and other health care professionals to assess upper extremity performance (coordination, dexterity and functioning). Items are categorized into four subscales (grasp, grip, pinch and gross movement) and arranged in order of decreasing difficulty, with the most difficult task examined first, followed by the least difficult task. Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performed normally).

    Measured: Through study completion, on average 24 weeks

  5. System Usability Scale

    Reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree

    Measured: Through study completion, on average 24 weeks

Secondary outcomes (3)
  1. Upper limb 3D position

    Upper limb 3D position will be measured with different virtual reality devices (Oculus Quest, htc Vive, REAtouch). This will be done thanks to the headset's infra-red camera or the controller's inertial measurement units.

    Measured: Through study completion, on average 24 weeks

  2. Upper limb peak velocity

    Upper limb peak velocity will be measured with different virtual reality devices (Oculus Quest, htc Vive, REAtouch). This will be done by deriving 3D position (obtained previously thanks to the headset's infra-red camera or the controller's inertial measurement units) and extracting highest value.

    Measured: Through study completion, on average 24 weeks

  3. Upper limb smoothness

    Upper limb smoothness will be measured with different virtual reality devices (Oculus Quest, htc Vive, REAtouch). This will be done by deriving three times 3D position (obtained previously thanks to the headset's infra-red camera or the controller's inertial measurement units) and converting it to a logarithmic dimensionless jerk. Second option is to measure a spectral arc length (also computed from 3D position)

    Measured: Through study completion, on average 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2021
  2. Study start23 Oct 2020
  3. Primary completion30 Aug 2022 (estimated)
  4. Study completion15 Oct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Studies will be conducted in a single group of (a) stroke patients and (b) healthy subjects
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04694833
Sponsor's protocol ID
ROBIGAME
Other IDs
1810108
Acronym
AutoRReVi
Status last verified
Jun 2022
First submitted
26 Nov 2020
Last updated
15 Jun 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sorrentino G, Edwards MG, Baldini N, Mustile M, Lejeune T, Everard G. REAsmash-ET: a methodological framework for combined cognitive and motor assessment through eye-tracking and kinematic metrics in immersive VR search-and-reach task. J Neuroeng Rehabil. 2025 Dec 17;23(1):25. doi: 10.1186/s12984-025-01844-0.

    PubMed 41408291
  • Everard G, Declerck L, Lejeune T, Edwards MG, Bogacki J, Reiprich C, Delvigne K, Legrain N, Batcho CS. A Self-Adaptive Serious Game to Improve Motor Learning Among Older Adults in Immersive Virtual Reality: Short-Term Longitudinal Pre-Post Study on Retention and Transfer. JMIR Aging. 2025 Mar 3;8:e64004. doi: 10.2196/64004.

    PubMed 40053708
  • Ajana K, Everard G, Lejeune T, Edwards MG. An immersive virtual reality serious game set for the clinical assessment of spatial attention impairments: Effects of avatars on perspective? Technol Health Care. 2025 Jul;33(4):1626-1644. doi: 10.1177/09287329241296380. Epub 2025 Jan 17.

    PubMed 39973878
  • Everard G, Burton Q, Van de Sype V, Bibentyo TN, Auvinet E, Edwards MG, Batcho CS, Lejeune T. Extended reality to assess post-stroke manual dexterity: contrasts between the classic box and block test, immersive virtual reality with controllers, with hand-tracking, and mixed-reality tests. J Neuroeng Rehabil. 2024 Mar 15;21(1):36. doi: 10.1186/s12984-024-01332-x.

    PubMed 38491540
  • Burton Q, Lejeune T, Dehem S, Lebrun N, Ajana K, Edwards MG, Everard G. Performing a shortened version of the Action Research Arm Test in immersive virtual reality to assess post-stroke upper limb activity. J Neuroeng Rehabil. 2022 Dec 3;19(1):133. doi: 10.1186/s12984-022-01114-3.

    PubMed 36463219
  • Everard G, Otmane-Tolba Y, Rosselli Z, Pellissier T, Ajana K, Dehem S, Auvinet E, Edwards MG, Lebleu J, Lejeune T. Concurrent validity of an immersive virtual reality version of the Box and Block Test to assess manual dexterity among patients with stroke. J Neuroeng Rehabil. 2022 Jan 22;19(1):7. doi: 10.1186/s12984-022-00981-0.

    PubMed 35065678

Questions about this trial

What is this clinical trial studying?

A study testing Motor and cognitive virtual reality-based assessments and Motor and cognitive virtual reality-based serious games in people with Stroke and Hemiparesis, run by Université Catholique de Louvain at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gauthier Everard, MSc, PT (+32472500158, gauthier.everard@uclouvain.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Upper Extremity Fugl-Meyer Assessment (time frame: Through study completion, on average 24 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04694833, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in